Low-Dose IL-2 Therapy in Refractory SLE: Results from Single Center Phase I/IIa Clinical Trial

被引：0
|
作者：
Humrich, Jens [1 ]
von Spee-Mayer, Caroline [2 ]
Siegert, Elise [3 ]
Rose, Angelika [2 ]
Bertolo, Martina [4 ]
Enghard, Philipp [5 ]
Hiepe, Falk [6 ]
Alexander, Tobias [3 ]
Feist, Eugen [6 ]
Radbruch, Andreas [7 ]
Burmester, Gerd R. [6 ]
Riemekasten, Gabriela [8 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Rheumatol, Campus Lubeck, Lubeck, Germany
[2] Charite, Rheumatol & Clin Immunol, Berlin, Germany
[3] Charite Univ Med Berlin, Rheumatol & Clin Immunol, Berlin, Germany
[4] Charite Univ Med Berlin, Dept Rheumatol, Berlin, Germany
[5] Charite Univ Med Berlin, Dept Nephrol, Berlin, Germany
[6] Charite, Berlin, Germany
[7] Deutsch Rheumaforschungszentrum, Berlin, Germany
[8] Univ Klinikum Schleswig Holstein, Dept Rheumatol, Lubeck, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13L
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
    Humrich, Jens Y.
    Von Spee-Mayer, Caroline
    Siegert, Elise
    Bertolo, Martina
    Rose, Angelika
    Abdirama, Dimas
    Enghard, Philipp
    Stuhlmueller, Bruno
    Sawitzki, Birgit
    Huscher, Doerte
    Hiepe, Falk
    Alexander, Tobias
    Feist, Eugen
    Radbruch, Andreas
    Burmester, Gerd-Ruediger
    Riemekasten, Gabriela
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (01): : E44 - E54
  • [42] Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
    Jyonouchi, Soma
    Gwafila, Brenda
    Gwalani, Lavesh A.
    Ahmad, Maria
    Moertel, Chistopher
    Holbert, Cecil
    Kim, Ji Young
    Kobrinsky, Nathan
    Roy-Ghanta, Sumita
    Orange, Jordan S.
    [J]. CLINICAL IMMUNOLOGY, 2017, 179 : 47 - 53
  • [43] Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy
    Lui, Jen Bon P.
    Malek, Thomas R.
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [44] A Phase I, Dose Escalation, Single Dose Trial of Oral AttenuatedSalmonella typhimuriumContaining Human IL-2 in Patients With Metastatic Gastrointestinal Cancers
    Gniadek, Thomas J.
    Augustin, Lance
    Schottel, Janet
    Leonard, Arnold
    Saltzman, Daniel
    Greeno, Edward
    Batist, Gerald
    [J]. JOURNAL OF IMMUNOTHERAPY, 2020, 43 (07) : 217 - 221
  • [45] Low-dose IL-2 Therapy Reduces HCV RNA and HBV DNA: Case Report
    Tomova, R.
    Antonov, K.
    Ivanova, A.
    Jacobs, J. J. L.
    Koten, J. W.
    Den Otter, W.
    Krastev, Z.
    [J]. ANTICANCER RESEARCH, 2009, 29 (12) : 5241 - 5244
  • [46] A low-dose combination therapy of IL-2 and IFNα for metastatic renal cell cancer.
    Akaza, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 424S - 424S
  • [47] The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with 1 diabetes
    Dong, Shen
    Hiam-Galvez, Kamir J.
    Mowery, Cody T.
    Herold, Kevan C.
    Gitelman, Stephen E.
    Esensten, Jonathan H.
    Liu, Weihong
    Lares, Angela P.
    Leinbach, Ashley S.
    Lee, Michael
    Nguyen, Vinh
    Tamaki, Stanley J.
    Tamaki, Whitney
    Tamaki, Courtney M.
    Mehdizadeh, Morvarid
    Putnam, Amy L.
    Spitzer, Matthew H.
    Ye, Chun Jimmie
    Tang, Qizhi
    Bluestone, Jeffrey A.
    [J]. JCI INSIGHT, 2021, 6 (18)
  • [48] A phase II trial of low-dose interleukin-2 (IL-2) and bevacizumab in patients with metastatic renal cell carcinoma (mRCC)
    Garcia, J. A.
    Rini, B. I.
    Mekhail, T.
    Triozzi, P.
    Elson, P.
    Nemec, C.
    Bukowski, R. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Multiple Subpopulations of Peripheral Lymphocytes Were Absolutely Decreased in SLE Patients with Infection and Restored By Low-Dose IL-2
    Zhang, Sheng-Xiao
    Wu, Xiao-Yan
    Luo, Jing
    Liu, Guang-Ying
    Gao, Chong
    Wang, Cai-Hong
    Li, Xiao-Feng
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] A Comprehensive Review of Low-Dose Interleukin-2 (IL-2) Therapy for Systemic Lupus Erythematosus: Mechanisms, Efficacy, and Clinical Applications
    Farooq, Amna
    Trehan, Shubam
    Singh, Gurjot
    Arora, Nirav
    Mehta, Tejal
    Jain, Prateek
    Bector, Gaurav
    Jain, Aayush
    Arora, Rajpreet S.
    Puri, Piyush
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
12345